Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Oocyte maturation requires a lot of energy, which is provided by the mitochondria via the synthesis of ATP. The majority of patients with advanced maternal age (AMA) have poor egg quality. One of the reasons depends on oxidative phosphorylation of Pyruvate to undergo maturation; on the contrary, the cells of the cumulus (CC) show great activity glycolytic so that these cells are able to provide ATP(adenosine triphosphate and energy substrates to the oocyte. The goal of this work is to analyze the mitochondrial function and energy production in oocyte donors compared with a group of women of advanced maternal age subject to a same ovarian stimulation Protocol
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| advanced maternal age | Infertile women due to advanced maternal age | ||
| Young patients | women under 35 undergoing infertility treatments |
Not provided
| Measure | Description | Time Frame |
|---|---|---|
| Adenosine Triphosphate (ATP) production (nmol) | ATP levels with the ATP assay kit (ab113849) Succinate dehydrogenase (SDH) activity assay kit (BioVision, USA) Mitochondrial Complex IV by colorimetric determination of oxidation-reduction processes of Cytochrome C | 15 days |
Not provided
Not provided
Inclusion Criteria:
Exclusion criteria:
For controls: Women with antral follicle count >20 or <6 follicle per ovary or with pathologies which, in the opinion of the investigator, may interfere with the treatment of ovarian stimulation
Cases
Not provided
Not provided
Controls: Young women between 18-35 years old with good reproductive prognostic undergoing COS (controlled ovarian stimulation) for IVF-ICSI
Cases: Infertile Women > 38 years old undergoing COS (controlled ovarian stimulation) for IVF-ICSI
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Juan A Garcia-Velasco, MD, PhD | IVI Madrid | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| IVI Madrid | Madrid | 28035 | Spain |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
serum, follicular fluid and granulosa cells